PATENT CLAIM ANALYSIS

Application Number: 16073746
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "001400"]

Abstract:
A compound of Formula (I), and its analogs are provided. Compositions that include Formula I can be used to inhibit human equilibrative nucleoside transporter 1, increase adenosine signaling and produce effects that include increasing antiviral activity, increasing antiparasitic activity, increasing alcohol tolerance, decreasing pain protecting from ischemia as well as many other conditions.

Claim (Index 7):
A method of increasing adenosine signaling comprising administering to a subject in need thereof an effective amount of a compound of  claim 5 , thereby increasing adenosine signaling.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.29167
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10558176', '12126810', '12742807', '14849782', '14898846']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7132095504026952
- 35 USC 102 Novelty (BERT): 0.5319900690976326
- Combined Prediction Score: 0.695087602272189
- Mean Citation Score: 239.658688
- Max Citation Score: 308.34003
- Similarity Product: 172.9121499187839

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test